We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image

U.S. 503B COMPOUNDING PHARMACIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 - 2030)

U.S. 503B Compounding Pharmacies Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/ Bupivacaine, Morphine, Amiodarone, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BKK (Bupivacaine, ketorolac, Ketamine), RCK (Ropivacaine, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Other Molecules), by Packaging Type (Vials, Pre-filled Syringes, Ampoule, Syringes, and Others)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In: 11 Aug, 2022
  • Code: CMI4481
  • Page number: 211
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Molecule
      • Market Snippet, By Packaging
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Pipeline Analysis
    • PEST Analysis
    • Regulatory Scenario
    • Market Trends
    • Key Highlights
    • Mergers & Acquisitions
  4. U.S 503B Compounding Pharmacies Market – Impact of Coronavirus (Covid-19) Pandemic

    • Economic Impact
    • Impact on Clinical Trials
    • Government Initiatives
  5. U.S 503B Compounding Pharmacies Market, By Molecule, 2017 – 2030, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Acetaminophen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Phenylephrine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Midazolam
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Esmolol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Vancomycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Epinephrine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Adenocaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Fentanyl/ Bupivacaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Morphine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Amiodarone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Heparin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Ketamine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Dextrose
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Hydromorphone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Bupivacaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Lidocaine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • BKK (Bupivacaine, ketorolac, Ketamine)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • RCK (Ropivacaine, Clonidine, Ketorolac)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • RKK (Ropivacaine, Ketorolac, Ketamine)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Other Molecules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  6. U.S. 503B Compounding Pharmacies Market, By Packaging, 2017 – 2030, (US$ Mn)

    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Vials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Prefilled Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Ampoules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  7. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
      • Central Admixture Pharmacy Services, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nephron Pharmaceuticals Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QuVa Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Olympia Pharmacy
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ASP Cares
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fagron Compounding Pharmacies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Athenex, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Avella Specialty Pharmacy
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Atlas Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Empower Pharmacy
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Carie Boyd’S Prescription Shop
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Edge Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Imprimis NJOF, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • IntegraDose Compounding services, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Wells Pharma of Houston, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • US Compounding Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SCA Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 6 market data tables and 32 figures on "U.S. 503B Compounding Pharmacies Market” - forecast to 2030.

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.